HonCode

Go Back   HER2 Support Group Forums > Breast Cancer Meeting Highlights
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Breast Cancer Meeting Highlights News fro recent ASCO and San Antonio Meetings

 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 01-05-2021, 03:24 PM   #1
Nguyen
Senior Member
 
Join Date: Nov 2005
Posts: 304
ARX788: A potential new treatment after T-DM1, Enhertu.

For some reason I can not post in "Articles of interest" section.

https://www.targetedonc.com/view/fda...BnbWFpbC5jb20=

http://ambrx.com/ambrx-presents-phas...cer-symposium/

ARX788, a Site-specific anti-HER2 Antibody Drug Conjugate, Demonstrates Potent and Selective Activity in HER2 Low and T-DM1 Resistant Breast and Gastric Cancers

https://sci-hub.se/https://mct.aacrj....full-text.pdf
Nguyen is offline   Reply With Quote
 

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On

Forum Jump


All times are GMT -7. The time now is 07:23 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2021, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter